271 related articles for article (PubMed ID: 26543366)
21. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
22. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.
Kumar N; Rai A; Reddy ND; Raj PV; Jain P; Deshpande P; Mathew G; Kutty NG; Udupa N; Rao CM
Pharmacol Rep; 2014 Oct; 66(5):788-98. PubMed ID: 25149982
[TBL] [Abstract][Full Text] [Related]
23. [Preparation of silymarin-loaded amphiphilic chitosan micelle and its in situ absorption in rat intestine].
Wu YP; Huo MR; Zhou JP
Yao Xue Xue Bao; 2009 Jun; 44(6):651-7. PubMed ID: 19806899
[TBL] [Abstract][Full Text] [Related]
24. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Liu Y; Luo X; Xu X; Gao N; Liu X
Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
[TBL] [Abstract][Full Text] [Related]
26. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
Wu W; Wang Y; Que L
Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
[TBL] [Abstract][Full Text] [Related]
27. A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity.
Hwang du H; Kim YI; Cho KH; Poudel BK; Choi JY; Kim DW; Shin YJ; Bae ON; Yousaf AM; Yong CS; Kim JO; Choi HG
J Microencapsul; 2014; 31(7):619-26. PubMed ID: 24766208
[TBL] [Abstract][Full Text] [Related]
28. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
He J; Hou SX; Feng JF; Cai BQ
Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
[TBL] [Abstract][Full Text] [Related]
29. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
Shi YJ; Zhang XF; Guo QT
Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance.
El-Samaligy MS; Afifi NN; Mahmoud EA
Int J Pharm; 2006 Aug; 319(1-2):121-9. PubMed ID: 16837151
[TBL] [Abstract][Full Text] [Related]
32. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
33. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway.
Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
Int J Pharm; 2015 May; 485(1-2):108-21. PubMed ID: 25735668
[TBL] [Abstract][Full Text] [Related]
34. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
35. Design and optimization of cranberry extract loaded bile salt augmented liposomes for targeting of MCP-1/STAT3/VEGF signaling pathway in DMN-intoxicated liver in rats.
M Soliman S; Mosallam S; Mamdouh MA; Hussein MA; M Abd El-Halim S
Drug Deliv; 2022 Dec; 29(1):427-439. PubMed ID: 35098843
[TBL] [Abstract][Full Text] [Related]
36. Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo.
Chu C; Tong SS; Xu Y; Wang L; Fu M; Ge YR; Yu JN; Xu XM
Acta Pharmacol Sin; 2011 Jul; 32(7):973-80. PubMed ID: 21666703
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.
Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA
J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568
[TBL] [Abstract][Full Text] [Related]
38. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
39. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells.
Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y
Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609
[TBL] [Abstract][Full Text] [Related]
40. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin.
Zhou X; Chen Z
Arch Pharm Res; 2015 Dec; 38(12):2193-200. PubMed ID: 26152876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
